Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. DELL
3. ROIV
4. LAD
5. TTE
6. ANET
7. NKE
8. BE
9. PANW
10. CL

Go back to Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: COAG) Delayed: 44.41 --0 (-0%)
Previous Close $44.41    52 Week High $ 
Open $44.41    52 Week Low $ 
Day High $44.41    P/E N/A 
Day Low $44.41    EPS $ 
Volume 3